|
시장보고서
상품코드
2035735
신경 조절 장치 시장 규모, 점유율 및 성장 분석 : 디바이스 유형별, 용도별, 최종사용자별, 유통 채널별, 지역별 - 업계 예측(2026-2033년)Neuromodulation Devices Market Size, Share, and Growth Analysis, By Device Type, By Application Area, By End User, By Distribution Channel, By Region - Industry Forecast 2026-2033 |
||||||
세계의 신경 조절 장치 시장 규모는 2024년에 110억 달러로 평가되었고, 2025년 115억 4,000만 달러에서 2033년까지 169억 2,000만 달러로 확대되어 예측 기간(2026-2033년)에 CAGR 4.9%를 보일 전망입니다.
세계 신경 조절 장치 시장은 만성질환 유병률 증가와 기존 약물 치료의 한계로 인해 괄목할 만한 성장세를 보이고 있습니다. 신경 자극 기술의 발전은 인간 신경의 기능적 특성과 다양한 질환의 치료에서 전기 자극의 효과에 대한 광범위한 조사에 의해 뒷받침되고 있습니다. 이에 따라 통증 완화를 위한 척수 자극, 간질 관리를 위한 미주신경 자극 등 새로운 기법과 기기의 개발이 진행되고 있습니다. 신경자극 분야의 지속적인 혁신을 반영하여 특정 질환을 대상으로 한 특화형 디바이스가 시장에 등장하고 있습니다. 그러나 신경조절 수술 및 장비에 따른 높은 비용, 숙련된 전문가 부족 등의 문제는 시장 성장을 저해하는 요인으로 작용할 수 있습니다.
세계 신경 조절 장치 시장의 성장요인
세계 신경 조절 장치 시장은 몇 가지 유력한 요인으로 인해 성장세를 보이고 있습니다. 주요 촉진요인 중 하나는 다양한 건강 상태의 유병률 증가이며, 이는 만성 통증, 편두통, 뇌 손상 등 다양한 질환의 완화에 이러한 기기가 효과적이라는 점을 강조하고 있습니다. 또한, 신경조절 기기는 정신질환, 소화기 질환, 수면장애를 관리하는 데 있어 그 역할이 점점 더 인정받고 있습니다. 이러한 다양한 의료 분야에 걸친 폭넓은 적용 가능성으로 인해 도입과 수용이 확대되고, 다양한 의료 요구에 대한 혁신적인 솔루션을 찾는 환자가 증가함에 따라 신경조절 기기 시장의 성장을 견인하고 있습니다.
세계 신경 조절 장치 시장 성장 억제요인
세계 신경조절 기기 시장은 성장을 저해하는 몇 가지 과제에 직면해 있습니다. 주요 장애물 중 하나는 막대한 설비투자가 필요하다는 점이며, 이는 특히 업계에서 입지를 다지려는 신규 진출기업에게 큰 장벽이 되고 있습니다. 또한, 이러한 장치와 관련된 높은 제조 비용도 스타트업에 더 많은 어려움을 가져다주고 있습니다. 이러한 문제를 더욱 심각하게 만드는 것은 뉴로모듈레이션 장치를 효과적으로 조작할 수 있는 숙련된 전문가가 부족하다는 점입니다. 이를 사용하기 위해서는 고도의 전문 지식과 훈련이 필요하기 때문입니다. 이러한 요인들이 복합적으로 작용하여 현재 시장 확대 가능성에 영향을 미치는 제약 요인이 되고 있습니다.
세계 신경변조기기 시장 동향
세계 신경조절 기기 시장은 요통, 우울증, 간질, 수면무호흡증과 같은 만성질환을 앓고 있는 환자 수 증가에 힘입어 괄목할 만한 성장세를 보이고 있습니다. 이들 질환은 기존 의약품에 내성을 보이는 경우가 많기 때문입니다. 이러한 의료 관리의 변화로 인해 의료 제공업체들은 대체 치료법으로 신경 자극 기술을 선호하게 되었고, 환자의 치료 결과를 개선하고 혁신적인 솔루션을 제공합니다. 의료계에서 신경조절기술이 지속적 질환의 증상 완화에 효과가 있다는 인식이 확산되고, 기기의 기능이 지속적으로 발전하고 개인 맞춤형 치료 계획에 대한 관심이 높아짐에 따라 시장이 확대될 것으로 예측됩니다.
자주 묻는 질문
목차
서론
조사 방법
주요 요약
시장 역학과 전망
주요 시장 인사이트
세계의 신경 조절 장치 시장 규모 : 디바이스 유형별
세계의 신경 조절 장치 시장 규모 : 용도별
세계의 신경 조절 장치 시장 규모 : 최종사용자별
세계의 신경 조절 장치 시장 규모 : 유통 채널별
세계의 신경 조절 장치 시장 규모 : 지역별
경쟁 정보
주요 기업 개요
결론과 제안
LSH 26.06.01Global Neuromodulation Devices Market size was valued at USD 11.0 Billion in 2024 and is poised to grow from USD 11.54 Billion in 2025 to USD 16.92 Billion by 2033, growing at a CAGR of 4.9% during the forecast period (2026-2033).
The global neuromodulation devices market is experiencing significant growth driven by the increasing prevalence of chronic conditions and the limitations of traditional pharmaceutical therapies. Advances in neurostimulation techniques are supported by extensive research on the functional properties of human nerves and the effectiveness of electrical stimulation in treating various ailments. This has led to the development of novel methods and devices, such as spinal cord stimulation for pain relief and vagus nerve stimulation for epilepsy management. The market is seeing the emergence of tailored devices aimed at specific conditions, reflecting ongoing innovation in neurostimulation. However, challenges such as the high costs associated with neuromodulation procedures and equipment, along with a shortage of skilled professionals, may impede market growth.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Neuromodulation Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Neuromodulation Devices Market Segments Analysis
Global Neuromodulation Devices Market is segmented by Device Type, Application Area, End User, Distribution Channel and region. Based on Device Type, the market is segmented into Transcranial Devices and Implantable Devices. Based on Application Area, the market is segmented into Chronic Pain Management and Mental Health. Based on End User, the market is segmented into Hospitals and Neurology Clinics. Based on Distribution Channel, the market is segmented into Direct Sales and Distributors. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Neuromodulation Devices Market
The global neuromodulation devices market is gaining momentum due to several compelling factors. A primary driver is the rising prevalence of various health conditions, which has highlighted the effectiveness of these devices in providing relief from a range of ailments, including chronic pain, migraines, and brain injuries. Furthermore, neuromodulation devices are increasingly recognized for their role in managing mental health disorders, digestive problems, and sleep disturbances. This broad applicability across multiple medical domains has led to heightened adoption and acceptance, ultimately fueling the growth of the neuromodulation devices market as more patients seek innovative solutions for their diverse healthcare needs.
Restraints in the Global Neuromodulation Devices Market
The global neuromodulation devices market faces several challenges that hinder its growth. A primary obstacle is the substantial capital investment required, which presents a significant barrier, particularly for new entrants seeking to establish themselves in the industry. Additionally, the high manufacturing costs associated with these devices create further difficulties for emerging players. Compounding these issues is the shortage of skilled professionals who can effectively operate neuromodulation devices, as their use demands a high level of expertise and training. Together, these factors contribute to the constraints currently affecting the market's potential for expansion.
Market Trends of the Global Neuromodulation Devices Market
The Global Neuromodulation Devices market is experiencing significant growth, fueled by an increasing patient population suffering from chronic conditions like back pain, depression, epilepsy, and sleep apnea, which often exhibit resistance to traditional pharmaceuticals. This evolution in healthcare management has led providers to prioritize neurostimulation techniques as alternative therapeutic options, enhancing patient outcomes and offering innovative solutions. As the medical community continues to recognize the efficacy of neuromodulation technologies in alleviating symptoms of these persistent disorders, the market is set to expand, marked by continuous advancements in device capabilities and an increasing focus on personalized treatment regimens.
Table of Contents
Introduction
- Objectives of the Study
- Market Definition & Scope
Research Methodology
- Research Process
- Secondary & Primary Data Methods
- Market Size Estimation Methods
Executive Summary
- Global Market Outlook
- Key Market Highlights
- Segmental Overview
- Competition Overview
Market Dynamics & Outlook
- Macro-Economic Indicators
- Drivers & Opportunities
- Restraints & Challenges
- Supply Side Trends
- Demand Side Trends
- Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Key Market Insights
- Key Success Factors
- Market Impacting Factors
- Top Investment Pockets
- Ecosystem Mapping
- Market Attractiveness Index 2025
- PESTEL Analysis
- Regulatory Landscape
Global Neuromodulation Devices Market Size by Device Type & CAGR (2026-2033)
- Market Overview
- Transcranial Devices
- Transcranial Magnetic Stimulation
- Pulse-TMS
- Theta Burst Stimulation
- Transcranial Direct Current Stimulation
- Anodal Stimulation
- Cathodal Stimulation
- Implantable Devices
- Deep Brain Stimulation
- High-Frequency Stimulation
- Burst Stimulation
- Spinal Cord Stimulation
- Conventional SCS
- Dorsal Root Ganglion Stimulation
Global Neuromodulation Devices Market Size by Application Area & CAGR (2026-2033)
- Market Overview
- Chronic Pain Management
- Back Pain
- Neuropathic Pain
- Mental Health
- Depression
- Anxiety Disorders
Global Neuromodulation Devices Market Size by End User & CAGR (2026-2033)
- Market Overview
- Hospitals
- Private Hospitals
- Public Hospitals
- Neurology Clinics
- Independent Clinics
- Networked Clinics
Global Neuromodulation Devices Market Size by Distribution Channel & CAGR (2026-2033)
- Market Overview
- Direct Sales
- Distributors
Global Neuromodulation Devices Market Size & CAGR (2026-2033)
- North America (Device Type, Application Area, End User, Distribution Channel)
- US
- Canada
- Europe (Device Type, Application Area, End User, Distribution Channel)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Device Type, Application Area, End User, Distribution Channel)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Device Type, Application Area, End User, Distribution Channel)
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa (Device Type, Application Area, End User, Distribution Channel)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2025
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2025
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)
Key Company Profiles
- Medtronic
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Boston Scientific
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Abbott Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Nevro Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Stimwave Technologies
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Helius Medical Technologies
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Nuvectra Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Soterix Medical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Brainstorm Cell Therapeutics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bioness
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- CHARITE - Universitatsmedizin Berlin
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Great Lakes NeuroTechnologies
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cerevel Therapeutics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cerenovus
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Refresh Neuro
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- IMThera Medical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- EBR Systems
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Synapse Biomedical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Analogue Devices
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- NeuroPace
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
